Biomedical Engineering Reference
In-Depth Information
170. Badawi, A. A., El-Laithy, H. M., El Qidra, R. K., El Mofty, H., and El dally, M. 2008. Chitosan
based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 31: 1040-1049.
171. Ammar, H. O., Salama, H. A., El-Nahhas, S. A., and Elmotasem, H. 2008. Design and evaluation
of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv 5: 290-298.
172. Lee, P. W., Hsu, S. H., Tsai, J. S., Chen, F. R., Huang, P. J., Ke, C. J., Liao, Z. X., Hsiao, C. W., Lin,
H. J., and Sung, H. W. 2010. Multifunctional core-shell polymeric nanoparticles for transdermal
DNA delivery and epidermal Langerhans cells tracking. Biomaterials 31: 2425-2434.
173. Koch, M. (West Pharmaceutical Services, Inc.). 2003. The growing market for nasal drug deliv-
ery. Business Briefing: Pharmatech .
174. Bossart, J., Sedo, K., and Kararli, T. T. 2010. Drug delivery products and technologies, a decade
in review: Approved products 2000 to 2009. Drug Deliv Technol 5: 28-31.
175. Brown, L. R. 2005. Commercial challenges of protein drug delivery. Expert Opin Drug Deliv 2:
29-42.
176. Gautier, S. 2009. Ultra-pure chitosan: Insight on new non-animal sources for use in advanced
drug delivery and cell therapy. Drug Deliv Technol 10: 20-21.
177. Kean, T. and Thanou, M. 2010. Biodegradation, biodistribution and toxicity of chitosan. Adv
Drug Deliv Rev 62: 3-11.
Search WWH ::




Custom Search